AnaptysBio, Inc. (ANAB)

48.92 +1.39 (+2.92%) USD  |  NASDAQ  |  Dec 19, 11:14
More

AnaptysBio Unrealized Gain (Loss) on Investment Securities (Quarterly)

Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Quarterly) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks
Start Trial
Ovid Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. --
Vanda Pharmaceuticals, Inc. --
CorMedix, Inc. --
Verastem, Inc. --